ABCL – AbCellera Biologics Inc.

Name : AbCellera Biologics Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $0.00000000000000

EPSttm :

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

ABCL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

18.32

Margin Of Safety %

Put/Call OI Ratio

0.42

EPS Next Q Diff

-0.04

EPS Last/This Y

-0.16

EPS This/Next Y

-0.07

Price

5.31

Target Price

10.43

Analyst Recom

1.22

Performance Q

48.46

Upside

-217.7%

Beta

1.22

Ticker: ABCL

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ABCL	5.27	0.27	0.59	75648
2026-05-12	ABCL	4.95	0.34	0.13	87290
2026-05-13	ABCL	4.78	0.33	0.15	89772
2026-05-14	ABCL	4.39	0.34	0.54	88614
2026-05-15	ABCL	4.11	0.33	0.64	89052
2026-05-18	ABCL	4.15	0.23	0.22	67170
2026-05-19	ABCL	4.06	0.23	0.67	70670
2026-05-20	ABCL	4.57	0.23	0.77	71847
2026-05-21	ABCL	5.13	0.35	0.90	88180
2026-05-22	ABCL	5.21	0.50	0.63	127618
2026-05-26	ABCL	5.27	0.50	0.08	128747
2026-05-27	ABCL	5.45	0.48	0.20	133264
2026-05-28	ABCL	5.73	0.47	0.12	135507
2026-05-29	ABCL	6.18	0.45	0.14	137699
2026-06-02	ABCL	6.12	0.44	0.28	141609
2026-06-03	ABCL	5.71	0.44	0.29	142572
2026-06-04	ABCL	6.36	0.45	0.05	142901
2026-06-05	ABCL	5.61	0.42	0.12	149883
2026-06-08	ABCL	5.42	0.42	0.03	150415
2026-06-09	ABCL	5.32	0.42	0.35	149895
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ABCL	5.25	-31.7	-	-0.74
2026-05-12	ABCL	4.95	-31.7	-	-0.74
2026-05-13	ABCL	4.78	-31.7	-	-0.74
2026-05-14	ABCL	4.39	-31.7	-	-0.74
2026-05-15	ABCL	4.09	-31.7	-	-0.74
2026-05-18	ABCL	4.15	-31.7	-	-0.66
2026-05-19	ABCL	4.06	-31.7	-	-0.66
2026-05-20	ABCL	4.57	-41.7	-	-0.66
2026-05-21	ABCL	5.13	-41.7	-	-0.66
2026-05-22	ABCL	5.21	-41.7	-	-0.66
2026-05-26	ABCL	5.29	-41.7	-	-0.65
2026-05-27	ABCL	5.45	-41.7	-	-0.65
2026-05-28	ABCL	5.74	-41.7	-	-0.65
2026-05-29	ABCL	6.18	-41.7	-	-0.65
2026-06-01	ABCL	6.46	-41.7	-	-0.65
2026-06-02	ABCL	6.12	-41.7	-	-0.65
2026-06-03	ABCL	5.70	-41.7	-	-0.65
2026-06-04	ABCL	6.36	-41.7	-	-0.65
2026-06-05	ABCL	5.61	-41.7	-	-0.65
2026-06-08	ABCL	5.43	-41.7	-	-0.65
2026-06-09	ABCL	5.31	-41.7	-	-0.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ABCL	0.00	-0.56	20.39
2026-05-12	ABCL	0.00	-0.56	19.00
2026-05-13	ABCL	0.00	-0.56	19.00
2026-05-14	ABCL	0.00	-0.56	18.86
2026-05-15	ABCL	0.00	-0.56	18.86
2026-05-18	ABCL	0.00	6.69	18.86
2026-05-19	ABCL	0.00	6.69	18.86
2026-05-20	ABCL	0.00	6.69	18.86
2026-05-21	ABCL	0.00	6.69	18.86
2026-05-22	ABCL	0.00	6.69	18.87
2026-05-26	ABCL	0.00	2.24	18.87
2026-05-27	ABCL	0.00	2.24	18.87
2026-05-28	ABCL	0.00	2.24	18.23
2026-05-29	ABCL	0.00	2.24	18.23
2026-06-02	ABCL	0.00	2.24	18.30
2026-06-03	ABCL	0.00	2.24	18.30
2026-06-04	ABCL	0.00	2.24	18.30
2026-06-05	ABCL	0.00	2.24	18.30
2026-06-08	ABCL	0.00	2.24	18.32
2026-06-09	ABCL	0.00	2.24	18.32
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL 589 360 ]

Last Quarter Act. EPS

-0.14

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

Institutional Transactions

2.24

Beta

1.22

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-92.5

Target Price

10.43

P/E

Forward P/E

PEG

P/S

20.43

P/B

1.72

P/Free Cash Flow

EPS

-0.48

Average EPS Est. Cur. Y

-0.65

EPS Next Y. (Est.)

-0.72

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-181.75

Relative Volume

0.86

Return on Equity vs Sector %

-42.8

Return on Equity vs Industry %

-26.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.05

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL 589 450 ]

◆ ABCL Healthcare

$5.30

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

15/25

Volume

4/15

Valuation

10/20

TP/AR

2/10

Options

8/10

RSI

51.6

Range 1M

46.1%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

12/30

Estimates

0/20

Inst/Vol

8/15

Options

7/10

EPS Yr

-20.4%

EPS NY

-9.2%

52W%

64%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +96.8% upside

Quality

6/30

Valuation

16/30

Growth

7/25

Stability

7/10

LT Trend

1/5

Upside

+96.8%

Quality

AbCellera Biologics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 562

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

[News_ABCL _Stock]

stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today

news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance

stock history ABCL – AbCellera Biologics Inc. invest stock market

stock prices ABCL premarket after hours

ticker ABCL fair value insiders trading

ABCL – AbCellera Biologics Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABCL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y